Evaluation of antibody and cytokine detection in tears of COVID-19 patients
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B342- Coronavirus infection, unspecified
- Registration Number
- CTRI/2020/11/028813
- Lead Sponsor
- PGIMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
COVID-19 positive patients will be recruited, including both adults and children.
A total of 90 COVID patients [mild disease (30 patients), moderate (30 patients) and severe (30 patients)] will be enrolled, as per the ICMR criteria, along with 30 healthy controls.
Exclusion Criteria
Patients not willing to give consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detection of cytokines and anti COVID antibodies in tear and blood samples of COVID-19 patientsTimepoint: 6-8 months
- Secondary Outcome Measures
Name Time Method Identification of tear biomarkers in COVID-19 patientsTimepoint: 6-8 months